Retrospective Cohort Study of Certolizumab Pegol and other anti-TNFs

• Research type

  Research Study

• Full title

  Retrospective Cohort Study of Certolizumab Pegol (Cimzia®) and Other Subcutaneous Anti-Tumour Necrosis Factor-Alpha Drugs in Rheumatoid Arthritis to Explore Usage Patterns and Clinical Outcomes in daily clinical practice in the United Kingdom

• IRAS ID

  119345

• Contact name

  Costantino Pitzalis

• Contact email

  c.pitzalis@qmul.ac.uk

• Sponsor organisation

  UCB Pharma Limited UK

• REC name

  London - West London & GTAC Research Ethics Committee

• REC reference

  13/LO/0020

• Date of REC Opinion

  18 Feb 2013

• REC opinion

  Further Information Favourable Opinion